BRADY JAMES ALOYSIUS sold 10.8% of their position (10.83K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $60.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/1/2026ACC: 0001916987-26-000002
Director
Since Mar 2025
-10.83K
Net shares
Net seller
$60.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.83K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.83K
Price / share
$5.54
Trade value
$60.04K
% of position
10.8%
3/30/2026
100K→89.17K
Total
Net shares
−10.83K
Net value
-$60.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/30/2026 | S · Sale | −10.83K | $5.54 | $60.04K | 10.8% | 100K | 89.17K |
| Total | −10.83K | -$60.04K | ||||||
Derivative Transactions0
No derivative transactions reported